- Home
- NRT vs KRRO Comparison
NRT vs KRRO Comparison
Compare NRT & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRT | KRRO |
|---|---|---|
| Founded | 1975 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 58.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | NRT | KRRO |
|---|---|---|
| Price | $7.85 | $9.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $74.17 |
| AVG Volume (30 Days) | 72.3K | ★ 216.5K |
| Earning Date | 12-31-2025 | 11-12-2025 |
| Dividend Yield | ★ 10.27% | N/A |
| EPS Growth | ★ 56.96 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $8,734,568.00 | $7,371,000.00 |
| Revenue This Year | N/A | $144.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.13 | ★ N/A |
| Revenue Growth | ★ 49.16 | N/A |
| 52 Week Low | $4.00 | $5.20 |
| 52 Week High | $8.35 | $55.89 |
Technical Indicators
Market Signals| Indicator | NRT | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 67.65 | 46.21 |
| Support Level | $7.18 | $7.82 |
| Resistance Level | $8.35 | $8.14 |
| Average True Range (ATR) | 0.34 | 0.48 |
| MACD | 0.15 | 0.67 |
| Stochastic Oscillator | 78.09 | 95.38 |
Price Performance
Historical ComparisonAbout NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.